1 Saifan C, "Warfarin-induced calciphylaxis : a case report and review of literature" 6 : 665-669, 2013
2 Caluwe R, "Vitamin K2 supplementation in haemodialysis patients : a randomized dose-finding study" 29 : 1385-1390, 2014
3 Binkley NC, "Vitamin K nutrition and osteoporosis" 125 : 1812-1821, 1995
4 Cranenburg EC, "Vitamin K intake and status are low in hemodialysis patients" 82 : 605-610, 2012
5 Feskanich D, "Vitamin K intake and hip fractures in women : a prospective study" 69 : 74-79, 1999
6 Krueger T, "Vitamin K deficiency in CKD patients: a modifiable risk factor for vascular calcification?" 76 : 18-22, 2009
7 Bancha Satirapoj, "Very low protein diet plus ketoacid analogs of essential amino acids supplement to retard chronic kidney disease progression" 대한신장학회 37 (37): 384-392, 2018
8 Hayden MR, "Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy : the emerging role of sodium thiosulfate" 4 : 4-, 2005
9 An WS, "Vascular calcification score on plain radiographs of the feet as a predictor of peripheral arterial disease in patients with chronic kidney disease" 42 : 773-780, 2010
10 An WS, "Vascular calcification on plain radiographs is associated with carotid intima media thickness, malnutrition and cardiovascular events in dialysis patients : a prospective observational study" 14 : 27-, 2013
11 Goodman WG, "Vascular calcification in chronic kidney disease" 43 : 572-579, 2004
12 Vergnaud P, "Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women : the EPIDOS Study" 82 : 719-724, 1997
13 Shroff RC, "The vascular biology of calcification" 20 : 103-109, 2007
14 Schafer C, "The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification" 112 : 357-366, 2003
15 Nestel P, "The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans" 76 : 326-330, 2002
16 Cranenburg EC, "The circulating inactive form of matrix Gla protein(ucMGP)as a biomarker for cardiovascular calcification" 45 : 427-436, 2008
17 Raggi P, "The ADVANCE study : a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis" 26 : 1327-1339, 2011
18 Barril-Cuadrado G, "Table showing dietary phosphorus/protein ratio for the Spanish population. Usefulness in chronic kidney disease" 33 : 362-371, 2013
19 Pilkey RM, "Subclinical vitamin K deficiency in hemodialysis patients" 49 : 432-439, 2007
20 Hermans MM, "Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis" 21 : 1293-1299, 2006
21 Mehta RL, "Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis" 88 : 252-257, 1990
22 Ogawa T, "Simple evaluation of aortic arch calcification by chest radiography in hemodialysis patients" 13 : 301-306, 2009
23 Tamashiro M, "Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis" 38 : 64-69, 2001
24 Kovesdy CP, "Serum phosphorus and the risk of progression of chronic kidney disease" 22 : 3679-3680, 2007
25 Kestenbaum B, "Serum phosphate levels and mortality risk among people with chronic kidney disease" 16 : 520-528, 2005
26 Wu-Wong JR, "Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification" 318 : 90-98, 2006
27 Booth SL, "Response of vitamin K status to different intakes and sources of phylloquinone-rich foods : comparison of younger and older adults" 70 : 368-377, 1999
28 Hruska KA, "Renal osteodystrophy, phosphate homeostasis, and vascular calcification" 20 : 309-315, 2007
29 김선철, "Relationship between pulmonary hypertension, peripheral vascular calcification, and major cardiovascular events in dialysis patients" 대한신장학회 34 (34): 28-34, 2015
30 Tonelli M, "Relation between serum phosphate level and cardiovascular event rate in people with coronary disease" 112 : 2627-2633, 2005
31 Ok E, "Reduction of dialysate calcium level reduces progression of coronary artery calcification and improves low bone turnover in patients on hemodialysis" 27 : 2475-2486, 2016
32 Russo D, "Pulse pressure and presence of coronary artery calcification" 4 : 316-322, 2009
33 Noordzij M, "Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients" 26 : 1662-1669, 2011
34 Verbeke F, "Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients : outcome of the calcification outcome in renal disease(CORD)study" 6 : 153-159, 2011
35 이자영, "Pre-existing arterial pathologic changes affecting arteriovenous fistula patency and cardiovascular mortality in hemodialysis patients" 대한내과학회 32 (32): 790-797, 2017
36 Ruiz-Gutierrez V, "Plasma lipids, erythrocyte membrane lipids and blood pressure of hypertensive women after ingestion of dietary oleic acid from two different sources" 14 : 1483-1490, 1996
37 Mirey Karavetian, "Patient education for hyperphosphatemia management: Improving outcomes while decreasing costs?" 대한신장학회 37 (37): 4-7, 2018
38 Block RC, "Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes?" 156 : 1117-1123, 2008
39 An WS, "Omega-3 fatty acid supplementation increases 1, 25-dihydroxyvitamin D and fetuin-A levels in dialysis patients" 32 : 495-502, 2012
40 Block GA, "Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients" 71 : 438-441, 2007
41 Tukaj C, "Morphological changes of aortal smooth muscle cells exposed to calcitriol in culture" 6 : 668-674, 2000
42 Vossen LM, "Menaquinone-7 supplementation to reduce vascular calcification in patients with coronary artery disease : rationale and study protocol(VitaK-CAC Trial)" 7 : 8905-8915, 2015
43 Shanahan CM, "Medial localization of mineralization-regulating proteins in association with Monckeberg’s sclerosis : evidence for smooth muscle cell-mediated vascular calcification" 100 : 2168-2176, 1999
44 Amann K, "Media calcification and intima calcification are distinct entities in chronic kidney disease" 3 : 1599-1605, 2008
45 황은아, "Management of chronic kidney disease–mineral and bone disorder: Korean working group recommendations" 대한신장학회 34 (34): 4-12, 2015
46 Kalantar-Zadeh K, "Malnutrition-inflammation complex syndrome in dialysis patients : causes and consequences" 42 : 864-881, 2003
47 Theuwissen E, "Lowdose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects" 108 : 1652-1657, 2012
48 Stenvinkel P, "Low fetuin-A levels are associated with cardiovascular death : impact of variations in the gene encoding fetuin" 67 : 2383-2392, 2005
49 Shinaberger CS, "Longitudinal associations between dietary protein intake and survival in hemodialysis patients" 48 : 37-49, 2006
50 Keelan PC, "Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography" 104 : 412-417, 2001
51 Fox CS, "Kidney function is inversely associated with coronary artery calcification in men and women free of cardiovascular disease : the Framingham Heart Study" 66 : 2017-2021, 2004
52 Garneata L, "Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression" 27 : 2164-2176, 2016
53 Kidney Disease: Improving Global Outcomes (KDIGO)CKD-MBD Work Group, "KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)" 76 (76): S1-S130, 2009
54 Kidney Disease: Improving Global Outcomes (KDIGO)CKD-MBD Update Work Group, "KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)" 7 : 1-59, 2017
55 Kidney Disease : Improving Global Outcomes(KDIGO)CKD Work Group, "KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease" 3 : 1-150, 2013
56 Hirata M, "In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1, 25(OH)2 vitamin D3" 18 : 1770-1776, 2003
57 Kim OY, "Impact of blood or erythrocyte membrane fatty acids for disease risk prediction: focusing on cardiovascular disease and chronic kidney disease" 10 : E1454-, 2018
58 Jung JY, "Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients" 25 : 4041-4048, 2010
59 Kanai S, "Eicosapentaenoic acid reduces warfarin-induced arterial calcification in rats" 215 : 43-51, 2011
60 Kim SJ, "Effects of low calcium dialysate on the progression of coronary artery calcification in hemodialysis patients : an open-label 12-month randomized clinical trial" 243 : 431-436, 2017
61 Oksa A, "Effects of longterm cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease" 31 : 322-329, 2008
62 임은수, "Effects of education on low-phosphate diet and phosphate binder intake to control serum phosphate among maintenance hemodialysis patients: A randomized controlled trial" 대한신장학회 37 (37): 69-76, 2018
63 Jwa-Kyung Kim, "Effects of Lowering Dialysate Calcium Concentrations on Arterial Stiffness in Patients Undergoing Hemodialysis" 대한내과학회 26 (26): 320-327, 2011
64 Westenfeld R, "Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients : a randomized trial" 59 : 186-195, 2012
65 An WS, "Effect of omega-3 fatty acids on the modification of erythrocyte membrane fatty acid content including oleic acid in peritoneal dialysis patients" 86 : 29-34, 2012
66 Dogan E, "Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients" 30 : 407-410, 2008
67 Schlemmer CK, "Ectopic calcification of rat aortas and kidneys is reduced with n-3fatty acid supplementation" 59 : 221-227, 1998
68 Helvig CF, "Dysregulation of renal vitamin D metabolism in the uremic rat" 78 : 463-472, 2010
69 Mizobuchi M, "Differential effects of vitamin D receptor activators on vascular calcification in uremic rats" 72 : 709-715, 2007
70 Geleijnse JM, "Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease : the Rotterdam Study" 134 : 3100-3105, 2004
71 Schurgers LJ, "Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations" 30 : 298-307, 2000
72 Chertow GM, "Determinants of progressive vascular calcification in haemodialysis patients" 19 : 1489-1496, 2004
73 진동찬, "Current characteristics of dialysis therapy in Korea: 2016 registry data focusing on diabetic patients" 대한신장학회 37 (37): 20-29, 2018
74 Russo D, "Coronary artery calcification in patients with CRF not undergoing dialysis" 44 : 1024-1030, 2004
75 An WS, "Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients" 19 : 267-274, 2009
76 Foley RN, "Clinical epidemiology of cardiovascular disease in chronic renal disease" 32 (32): S112-S119, 1998
77 Matias PJ, "Cholecalciferol supplementation in hemodialysis patients : effects on mineral metabolism, inflammation, and cardiac dimension parameters" 5 : 905-911, 2010
78 Garcia-Lopes MG, "Cholecalciferol supplementation in chronic kidney disease : restoration of vitamin D status and impact on parathyroid hormone" 61 : 74-82, 2012
79 Zheng CM, "Cholecalciferol additively reduces serum parathyroid hormone levels in severe secondary hyperparathyroidism treated with calcitriol and cinacalcet among hemodialysis patients" 10 : 2018
80 Zheng JQ, "Cholecalciferol additively reduces serum parathyroid hormone and increases vitamin D and cathelicidin levels in paricalcitol-treated secondary hyperparathyroid hemodialysis patients" 8 : E708-, 2016
81 Cranenburg EC, "Characterisation and potential diagnostic value of circulating matrix Gla protein(MGP)species" 104 : 811-822, 2010
82 Sokoll LJ, "Changes in serum osteocalcin, plasma phylloquinone, and urinary gamma-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects" 65 : 779-784, 1997
83 이미정, "Changes in geriatric nutritional risk index and risk of major adverse cardiac and cerebrovascular events in incident peritoneal dialysis patients" 대한신장학회 36 (36): 377-386, 2017
84 Braam LA, "Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women : a follow-up study" 91 : 373-380, 2004
85 Nishizawa Y, "Atherosclerosis in uremia : possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation" 62 : S90-, 1997
86 Shoji T, "Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis" 131 : 229-236, 1997
87 Booth SL, "Associations between vitamin K biochemical measures and bone mineral density in men and women" 89 : 4904-4909, 2004
88 안원석, "Associations between Oxidized LDL to LDL Ratio, HDL and Vascular Calcification in the Feet of Hemodialysis Patients" 대한의학회 24 : 115-120, 2009
89 Shoben AB, "Association of oral calcitriol with improved survival in nondialyzed CKD" 19 : 1613-1619, 2008
90 Kovesdy CP, "Association of activated vitamin D treatment and mortality in chronic kidney disease" 168 : 397-403, 2008
91 Son YK, "Association between vascular calcification scores on plain radiographs and fatty acid contents of erythrocyte membrane in hemodialysis patients" 22 : 58-66, 2012
92 Price PA, "Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate" 70 : 1577-1583, 2006
93 Guerin AP, "Arterial stiffening and vascular calcifications in end-stage renal disease" 15 : 1014-1021, 2000
94 London GM, "Arterial media calcification in end-stage renal disease : impact on all-cause and cardiovascular mortality" 18 : 1731-1740, 2003
95 Blacher J, "Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease" 38 : 938-942, 2001
96 Nitta K, "Aortic arch calcification and clinical outcome in patients with end-stage renal disease" 223 : 79-84, 2011
97 Paganelli F, "Altered erythrocyte n-3 fatty acids in Mediterranean patients with coronary artery disease" 78 : 27-32, 2001
98 Lee SM, "Abdominal aortic calcification score among several vascular calcification scores of plain radiograph is the most reliable predictor of severe coronary artery calcification in dialysis patients" 39 : 729-735, 2017
99 Honkanen E, "Abdominal aortic calcification in dialysis patients : results of the CORD study" 23 : 4009-4015, 2008
100 Adragao T, "A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients" 19 : 1480-1488, 2004
101 Wetmore JB, "A randomized trial of cinacalcet versus vitamin D analogs as monotherapy in secondary hyperparathyroidism(PARADIGM)" 10 : 1031-1040, 2015
102 Adragao T, "A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients" 24 : 997-1002, 2009
103 Hall WL, "A high-fat meal enriched with eicosapentaenoic acid reduces postprandial arterial stiffness measured by digital volume pulse analysis in healthy men" 138 : 287-291, 2008
104 Henley C, "1, 25-Dihydroxyvitamin D3 but not cinacalcet HCl(Sensipar/Mimpara)treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism" 20 : 1370-1377, 2005